Cardinal Health Inc (CAH)
| Market Cap | 54.37B+48.2% |
| Revenue (ttm) | n/a+14.2% |
| Net Income | n/a+9.8% |
| EPS | n/a+12.1% |
| Shares Out | 234.21M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,096,741 |
| Open | 233.61 |
| Previous Close | 233.44 |
| Day's Range | 230.59 - 235.97 |
| 52-Week Range | 151.87 - 258.30 |
| Beta | n/a |
| Analysts | Buy |
| Price Target | 273.22(+17.69%) |
| Earnings Date | n/a |
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
About CAH
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company offers customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$CAH stock is featured in our Insider Score Rankings, Congress Trading, and Insider Trades datasets.
→ All Stock ListsCongress Trading
Recent trades of CAH by members of U.S. Congress
| Politician | Type | Traded |
|---|---|---|
| Alan ArmstrongSenate / R | Purchase$1.00K – $15.00K | Mar 27, 2026 |
| Jonathan JacksonHouse / D | Purchase$50.00K – $100.00K | Jan 12, 2024 |
| Jonathan JacksonHouse / D | Purchase$50.00K – $100.00K | Jan 11, 2024 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 18, 2020 |
| Gilbert CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 18, 2020 |
| Gilbert Ray CisnerosHouse / D | Purchase$1.00K – $15.00K | Mar 17, 2020 |
Recently reported changes in CAH holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by CAH's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
CAH Estimated quarterly lobbying spending
Source: U.S. Senate LDA
CAH Revenue by Segment
| Segment | Revenue | % of All |
|---|---|---|
| Cost of products sold | $244.47B | 49.01% |
| Pharmaceutical and Specialty Solutions | $234.83B | 47.08% |
| GMPD | $12.72B | 2.55% |
| Other Operating Segment | $6.79B | 1.36% |
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-K)
U.S. Patents
New CAH patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to CAH from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in CAH
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $1.75B |
| VOOVanguard S&P 500 ETF | $1.46B |
| VOVanguard Morningstar Mid-Cap ETF | $1.19B |
| IVViShares Core S&P 500 ETF | $723.38M |
| SPYState Street SPDR S&P 500 ETF | $657.59M |
| AFTYPacer CSOP FTSE China A50 ETF | $544.52M |
Estimated from each fund’s disclosed top holdings × AUM
CAH Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from CAH’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score